Xilio Therapeutics (XLO) Short Interest Ratio & Short Volume → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free XLO Stock Alerts $1.21 -0.05 (-3.97%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Xilio Therapeutics Short Interest DataCurrent Short Volume379,500 sharesPrevious Short Volume54,200 sharesChange Vs. Previous Month+600.18%Dollar Volume Sold Short$478,170.00Short Interest Ratio / Days to Cover0.3Last Record DateApril 15, 2024Outstanding Shares36,910,000 sharesFloat Size8,720,000 sharesShort Percent of Float4.35%Today's Trading Volume157,661 sharesAverage Trading Volume951,284 sharesToday's Volume Vs. Average17% Short Selling Xilio Therapeutics ? Sign up to receive the latest short interest report for Xilio Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXLO Short Interest Over TimeXLO Days to Cover Over TimeXLO Percentage of Float Shorted Over Time Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Xilio Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024379,500 shares $478,170.00 +600.2%4.4%0.3 $1.26 3/31/202454,200 shares $58,536.00 -5.9%0.7%0 $1.08 3/15/202457,600 shares $39,456.00 +171.7%0.4%0.3 $0.69 2/29/202421,200 shares $15,030.80 -37.3%0.2%0.1 $0.71 2/15/202433,800 shares $19,854.12 +2,012.5%0.2%0.2 $0.59 1/31/20241,600 shares $1,040.00 -75.4%0.0%0 $0.65 Get the Latest News and Ratings for XLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xilio Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20246,500 shares $4,831.45 +364.3%0.1%0 $0.74 12/31/20231,400 shares $770.00 -92.5%0.0%0 $0.55 12/15/202318,600 shares $13,206.00 -65.6%0.1%0.4 $0.71 11/30/202354,100 shares $51,395.00 +86.6%0.4%2.2 $0.95 11/15/202329,000 shares $38,860.00 +14.6%0.2%1.5 $1.34 10/31/202325,300 shares $54,395.00 -4.5%0.2%1.7 $2.15 10/15/202326,500 shares $46,375.00 +7.7%0.2%2.2 $1.75 9/30/202324,600 shares $51,906.00 +98.4%0.2%2.1 $2.11 9/15/202312,400 shares $29,264.00 -77.0%0.1%1.1 $2.36 8/31/202353,900 shares $154,693.00 -2.7%0.4%4 $2.87 8/15/202355,400 shares $151,242.00 -7.1%0.4%4.2 $2.73 7/31/202359,600 shares $170,456.00 -23.6%0.4%4.1 $2.86 7/15/202378,000 shares $206,700.00 -4.5%0.6%4.9 $2.65 6/30/202381,700 shares $214,054.00 -46.2%0.6%3.6 $2.62 6/15/2023151,800 shares $414,414.00 -21.4%1.2%6.5 $2.73 5/31/2023193,100 shares $588,955.00 -3.3%1.5%8.9 $3.05 5/15/2023199,600 shares $612,772.00 +1.0%1.7%7.6 $3.07 4/30/2023197,600 shares $652,080.00 -12.1%1.8%7 $3.30 4/15/2023224,700 shares $741,510.00 +25.7%2.0%4.3 $3.30 3/31/2023178,700 shares $566,479.00 +58.6%1.6%3.4 $3.17 3/15/2023112,700 shares $311,052.00 +160.9%1.0%2.2 $2.76 2/28/202343,200 shares $155,952.00 +77.1%0.4%0.9 $3.61 2/15/202324,400 shares $77,592.00 -62.6%0.3%0.5 $3.18 1/31/202365,200 shares $237,980.00 +239.6%0.7%1.3 $3.65 1/15/202319,200 shares $51,072.00 -31.4%0.2%0.5 $2.66 12/30/202228,000 shares $75,320.00 +1.8%0.3%1 $2.69 12/15/202227,500 shares $62,700.00 -0.7%0.3%0.9 $2.28 11/30/202227,700 shares $67,034.00 +12.2%0.3%0.3 $2.42 11/15/202224,700 shares $59,280.00 +34.2%0.3%0.3 $2.40 10/31/202218,400 shares $43,056.00 -41.4%0.2%0.2 $2.34 10/15/202231,400 shares $72,220.00 -34.0%0.3%0.3 $2.30 9/30/202247,600 shares $138,516.00 -15.3%0.5%0.4 $2.91 9/15/202256,200 shares $177,030.00 +72.4%0.6%0.4 $3.15 8/31/202232,600 shares $73,024.00 -45.4%0.3%0.3 $2.24READ THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. XLO Short Interest - Frequently Asked Questions What is Xilio Therapeutics' current short interest? Short interest is the volume of Xilio Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 379,500 shares of XLO short. 4.35% of Xilio Therapeutics' shares are currently sold short. Learn More on Xilio Therapeutics' current short interest. What is a good short interest percentage for Xilio Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.35% of Xilio Therapeutics' floating shares are currently sold short. Is Xilio Therapeutics' short interest increasing or decreasing? Xilio Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 379,500 shares, an increase of 600.2% from the previous total of 54,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Xilio Therapeutics' float size? Xilio Therapeutics currently has issued a total of 36,910,000 shares. Some of Xilio Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Xilio Therapeutics currently has a public float of 8,720,000 shares. How does Xilio Therapeutics' short interest compare to its competitors? 4.35% of Xilio Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Xilio Therapeutics: Apollomics, Inc. (0.32%), ProMIS Neurosciences, Inc. (0.16%), Unicycive Therapeutics, Inc. (1.53%), Lexaria Bioscience Corp. (3.70%), Marker Therapeutics, Inc. (1.00%), Cara Therapeutics, Inc. (5.62%), Eyenovia, Inc. (10.56%), VYNE Therapeutics Inc. (0.80%), Acurx Pharmaceuticals, Inc. (4.80%), BriaCell Therapeutics Corp. (4.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Xilio Therapeutics stock? Short selling XLO is an investing strategy that aims to generate trading profit from Xilio Therapeutics as its price is falling. XLO shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xilio Therapeutics? A short squeeze for Xilio Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XLO, which in turn drives the price of the stock up even further. How often is Xilio Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XLO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Apollomics Short Squeeze ProMIS Neurosciences Short Squeeze Unicycive Therapeutics Short Squeeze Lexaria Bioscience Short Squeeze Marker Therapeutics Short Squeeze Cara Therapeutics Short Squeeze Eyenovia Short Squeeze VYNE Therapeutics Short Squeeze Acurx Pharmaceuticals Short Squeeze BriaCell Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XLO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press